KeyMed Biosciences (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the supplemental New Drug Application (the "sNDA") of ...

While an admirable goal, it can be challenging for consumers to determine where a product is made based solely on its ...

The Company expects that its cash resources at December 31, 2024, and the gross proceeds of approximately $30.4 million raised from sales under its at-the-market facility in the first quarter of 2025, ...

Nasal irrigation can be a useful addition to the management of chronic upper respiratory conditions, including nasal ...

A report from the National Weather Service was issued on Friday at 12:15 a.m. for strong thunderstorms until 1:15 a.m. The ...